TTEC

2.6007.80%
TL

Tracy L. Bahl

Independent Director

Mr. Tracy L. Bahl serves as the Managing Director of Valtruis LLC. Mr. Tracy has been Executive Chairman of Board at Andros Technologies Inc. since April 2021. He served as Independent Director at InterWell Health, LLC since November 2022 until 2025. He has been Director of Glooko, Inc. Mr. Bahl has been an Independent Director of TTEC Holdings, Inc. (formerly known as TeleTech Holdings, Inc.) since July 30, 2013. He serves as Managing Partner of Valtruis. He serves as Managing Director at Valtruis, a WCAS company focused on investing in organizations leading the transformation to value-based care. He serves as a Director of Axial Healthcare Holdings, L.P. He serves as Director of Cricket Health, Inc. He served as an Operating Partner at Welsh, Carson, Anderson & Stowe since joining the firm from January 20, 2021 to May 2024. In 2020, he joined the board of Glooko. He also serves as an advisor to Cricket Health, SCALE Physician Group and C2FO. Previously, Mr. Bahl served as the President and CEO of OneOncology. Mr. Bahl served as executive vice president, health plans for CVS Health since 2013 until 2018. He served as a special advisor to General Atlantic Service Company, L.P. since 2007 until 2013, where he focused on healthcare services and technology investments. Mr. Bahl served as a member of the board of directors of MedExpress since 2013 until 2015 and also since 2008 until 2011 as an executive chairman for Emdeon (now Change Healthcare). Prior to 2007, Mr. Bahl held various senior executive positions as part of UnitedHealth Group, including between 2004 and 2007 as the chief executive officer of Uniprise, between 2002 and 2004 as chief marketing officer for UnitedHealth Group. Prior to UnitedHealth Group, Mr. Bahl was an executive with CIGNA Healthcare. He serves as Executive Chairman at Andros since April 2021. He has experience in the healthcare services industry. Mr. Bahl also serves as trustee of the Board of Trustees of Gustavus Adolphus College in St. Peter, MN. Mr. Bahl serves as member of the board of directors for Wayspring Health and Oncology Care Partners. He received dual M.B.A. degree from Columbia University as well as an MBA degree from London Business School and a B.A. degree in Business Administration, Health Science and Exercise Science from Gustavus Adolphus College.

Positions